chr11-5226764-A-G
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000335295.4(HBB):c.128T>C(p.Phe43Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F43L) has been classified as Pathogenic.
Frequency
Consequence
ENST00000335295.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBB | NM_000518.5 | c.128T>C | p.Phe43Ser | missense_variant | 2/3 | ENST00000335295.4 | NP_000509.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBB | ENST00000335295.4 | c.128T>C | p.Phe43Ser | missense_variant | 2/3 | 1 | NM_000518.5 | ENSP00000333994 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 36
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Dec 15, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 25, 2022 | Identified in a 6 month old male with hemolytic anemia and cyanosis in published literature (Park et al., 2012); Published functional studies suggest a damaging effect resulting in lower oxygen affinity and increased 2,3-DPG concentration (May et al., 1975); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as Hb Hammersmith; This variant is associated with the following publications: (PMID: 1911375, 19429541, 24471820, 1201210, 29084024, 22217314) - |
beta Thalassemia Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 17, 2017 | - - |
Heinz body anemia Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 1988 | - - |
HEMOGLOBIN HAMMERSMITH Other:1
other, no assertion criteria provided | literature only | OMIM | Jun 01, 1988 | - - |
HEMOGLOBIN CHIBA Other:1
other, no assertion criteria provided | literature only | OMIM | Jun 01, 1988 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at